Meilax



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Insomnia 24.5%
Anxiety 13.8%
Depression 12.4%
Drug Use For Unknown Indication 9.1%
Panic Disorder 9.1%
Hypertension 4.6%
Product Used For Unknown Indication 4.0%
Rheumatoid Arthritis 3.9%
Constipation 3.2%
Epilepsy 1.9%
Drug Abuse 1.8%
Bipolar Disorder 1.4%
Cerebral Infarction 1.4%
General Anaesthesia 1.4%
Neurosis 1.4%
Prostate Cancer 1.4%
Restlessness 1.4%
Intentional Overdose 1.2%
Angina Pectoris 1.1%
Proctalgia 1.1%
Respiratory Disorder Neonatal 10.8%
Rhabdomyolysis 9.5%
Stevens-johnson Syndrome 6.8%
Suicide Attempt 6.8%
Tachycardia 6.8%
Altered State Of Consciousness 5.4%
Delirium 5.4%
Self Injurious Behaviour 5.4%
Interstitial Lung Disease 4.1%
Loss Of Consciousness 4.1%
Overdose 4.1%
Pyrexia 4.1%
Somnolence 4.1%
Viral Infection 4.1%
Visual Acuity Reduced 4.1%
Vomiting 4.1%
Activation Syndrome 2.7%
Deafness 2.7%
Drug Toxicity 2.7%
Dysuria 2.7%
Concomitant
Depression 21.4%
Insomnia 13.0%
Hypertension 9.2%
Anxiety 7.1%
Drug Use For Unknown Indication 6.3%
Product Used For Unknown Indication 5.4%
Prophylaxis 4.6%
Schizophrenia 4.2%
Constipation 4.2%
Hepatitis C 2.7%
Rheumatoid Arthritis 2.6%
Asthma 2.6%
Bipolar Disorder 2.4%
Pain 2.4%
Gastritis 2.3%
Panic Disorder 2.2%
Anxiety Disorder 2.1%
Analgesic Therapy 2.0%
Crohn's Disease 1.7%
Osteoporosis 1.6%
Rhabdomyolysis 10.0%
Suicide Attempt 9.5%
Hepatic Function Abnormal 6.6%
Tumour Lysis Syndrome 6.6%
Liver Disorder 6.2%
Pyrexia 6.2%
Suicidal Ideation 6.2%
White Blood Cell Count Decreased 6.2%
White Blood Cell Count Increased 6.2%
Somnolence 3.7%
Ventricular Tachycardia 3.7%
Interstitial Lung Disease 3.3%
Multiple Drug Overdose Intentional 3.3%
Nausea 3.3%
Off Label Use 3.3%
Pancreatitis Acute 3.3%
Vomiting 3.3%
Intentional Overdose 2.9%
Overdose 2.9%
Tremor 2.9%